The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Cardiomyopathy in obesity, insulin resistance and diabetes
Open accessAbstract
The prevalence of obesity, insulin resistance and diabetes is increasing rapidly. Most patients with these disorders have hypertriglyceridaemia and increased plasma levels of fatty acids, which are taken up and stored in lipid droplets in the heart. Intramyocardial lipids that exceed the capacity for storage and oxidation can be lipotoxic and induce non‐ischaemic and non‐hypertensive cardiomyopathy, termed diabetic or lipotoxic cardiomyopathy. The clinical features of diabetic cardiomyopathy are cardiac hypertrophy and diastolic dysfunction, which lead to heart failure, especially heart failure with preserved ejection fraction. Although the pathogenesis of the cardiomyopathy is multifactorial, diabetic dyslipidaemia and intramyocardial lipid accumulation are the key pathological features, triggering cellular signalling and modifications of proteins and lipids via generation of toxic metabolic intermediates. Most clinical studies have shown no beneficial effect of anti‐diabetic agents and statins on outcomes in heart failure patients without atherosclerotic diseases, indicating the importance of identifying underlying mechanisms and early interventions for diabetic cardiomyopathy. Here, we summarize the molecular mechanisms of diabetic cardiomyopathy, with a special emphasis on cardiac lipotoxicity, and discuss the role of peroxisome proliferator‐activated receptor α and dysregulated fatty acid metabolism as potential therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Lee, I.-M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., & Katzmarzyk, P. T. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61031-9 · Cited by 8,215
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“Although diabetic cardiomyopathy may be asymptomatic, patients with diabetic cardiomyopathy and symptomatic HF should be treated as established HF patients without diabetic cardiomyopathy (Marwick et al. 2018).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32225-6 · Cited by 4,943
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“Indeed, clinical studies have shown that fibrates reduce the incidence of cardiovascular events in patients with diabetes or metabolic disorders (VA-HIT (Rubins et al. 2002), a post hoc analysis of FIELD (Scott et al. 2009), and Helsinki Heart Study (Frick et al. 1987)).”
BackgroundTLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
The economic burden of physical inactivity: a global analysis of major non-communicable diseases
Ding, D., Lawson, K. D., Kolbe-Alexander, T. L., Finkelstein, E. A., Katzmarzyk, P. T., van Mechelen, W., & Pratt, M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30383-x · Cited by 2,201
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
Understanding the diversity of membrane lipid composition
Harayama, T., & Riezman, H. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.138 · Cited by 2,046
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Self-citationNegative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 1×
“Fatty acids, especially saturated fatty acids, are directly and indirectly recognized by TLR4 in various cell types, including monocytes/macrophages, leading to activation of TLR4 signalling pathways (Lee et al. 2001; Shi et al. 2006; Stewart et al. 2010; Eguchi et al. 2012).”
BackgroundRosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487 · cited 1×
“…death has not been established in patients with chronic HF, in part due to cardiac death induced by non-atherosclerotic, non-coronary occlusive mechanisms in HF patients (Kjekshus et al. 2007; Tavazzi et al. 2008; Cholesterol Treatment Trialists’ (CTT) Collaboration et al. 2010; Liu et al. 2014).”
BackgroundSilverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483 · cited 1×
“…analysis of 49 clinical trials showed that fibrates provide a greater risk reduction than the expected relative risk based on the degree of LDL-C reduction (Silverman et al. 2016), suggesting an additive effect of fibrates on LDL-C reduction via upregulation of LDL receptor expression.”
BackgroundMembrane lipid composition and cellular function.
Spector, A. A., & Yorek, M. A. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34276-0 · Cited by 1,480
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000510 · Cited by 1,386
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106
Role of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Bray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00271-3 · Cited by 1,036
Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Adams, T. D., Davidson, L. E., Litwin, S. E., Kim, J., Kolotkin, R. L., Nanjee, M. N., Gutierrez, J. M., Frogley, S. J., Ibele, A. R., Brinton, E. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700459 · Cited by 956
Impact of Diabetes on Cardiac Structure and Function: The Strong Heart Study
Devereux, R. B., Roman, M. J., Paranicas, M., O’Grady, M. J., Lee, E. T., Welty, T. K., Fabsitz, R. R., Robbins, D., Rhoades, E. R., & Howard, B. V. (2000) · Circulation · doi:10.1161/01.cir.101.19.2271 · Cited by 942
(2012) · British Dental Journal · doi:10.1038/sj.bdj.2012.909 · Cited by 906
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816
Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jørgensen, M. E., Thuresson, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029190 · Cited by 813
The war against heart failure: the Lancet lecture
Braunwald, E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61889-4 · Cited by 811
Mitochondrial function as a therapeutic target in heart failure
Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.203 · Cited by 803
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., & Taegtmeyer, H. (2004) · The FASEB Journal · doi:10.1096/fj.04-2263com · Cited by 790
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Haemmerle, G., Moustafa, T., Woelkart, G., Büttner, S., Schmidt, A., van de Weijer, T., Hesselink, M., Jaeger, D., Kienesberger, P. C., Zierler, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2439 · Cited by 761
Malmberg, K., Yusuf, S., Gerstein, H. C., Brown, J., Zhao, F., Hunt, D., Piegas, L., Calvin, J., Keltai, M., Budaj, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.1014 · Cited by 750
Glycemic Control and Heart Failure Among Adult Patients With Diabetes
Iribarren, C., Karter, A. J., Go, A. S., Ferrara, A., Liu, J. Y., Sidney, S., & Selby, J. V. (2001) · Circulation · doi:10.1161/01.cir.103.22.2668 · Cited by 710
Mega, J. L., Stitziel, N. O., Smith, J. G., Chasman, D. I., Caulfield, M. J., Devlin, J. J., Nordio, F., Hyde, C. L., Cannon, C. P., Sacks, F. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61730-x · Cited by 704
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804989 · Cited by 698
Arany, Z., He, H., Lin, J., Hoyer, K., Handschin, C., Toka, O., Ahmad, F., Matsui, T., Chin, S., Wu, P.-H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.002 · Cited by 694
Innate Immunity and the Failing Heart: The Cytokine Hypothesis Revisited
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 689
Würtz, P., Havulinna, A. S., Soininen, P., Tynkkynen, T., Prieto-Merino, D., Tillin, T., Ghorbani, A., Artati, A., Wang, Q., Tiainen, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013116 · Cited by 677
Metra, M., & Teerlink, J. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31071-1 · Cited by 673
Peterson, L. R., Herrero, P., Schechtman, K. B., Racette, S. B., Waggoner, A. D., Kisrieva-Ware, Z., Dence, C., Klein, S., Marsala, J., Meyer, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127959.28627.f8 · Cited by 656
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., Flather, M., Glynn, R. J., Gregoire, J., Jukema, J. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701488 · Cited by 624
Cardiac Steatosis in Diabetes Mellitus: A 1 H-Magnetic Resonance Spectroscopy Study
McGavock, J. M., Lingvay, I., Zib, I., Tillery, T., Salas, N., Unger, R., Levine, B. D., Raskin, P., Victor, R. G., & Szczepaniak, L. S. (2007) · Circulation · doi:10.1161/circulationaha.106.645614 · Cited by 612 · cited 1×
“…Intensive lowering of LDL-C with statins is widely accepted as beneficial in the primary and secondary prevention of CVD and mortality, especially in patients with a higher genetic risk score (Cholesterol Treatment Trialists’ (CTT) Collaboration et al. 2010; Mega et al. 2015; Collins et al. 2016).”
Background(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Lipid Metabolism and Toxicity in the Heart
Goldberg, I. J., Trent, C. M., & Schulze, P. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.006 · Cited by 589
Rubins, H. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2597 · Cited by 586
Vos, M. B., Kaar, J. L., Welsh, J. A., Van Horn, L. V., Feig, D. I., Anderson, C. A. M., Patel, M. J., Cruz Munos, J., Krebs, N. F., Xanthakos, S. A., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000439 · Cited by 580
Stegemann, C., Pechlaner, R., Willeit, P., Langley, S. R., Mangino, M., Mayr, U., Menni, C., Moayyeri, A., Santer, P., Rungger, G., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.002500 · Cited by 564
Rijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., Romijn, J. A., de Roos, A., & Lamb, H. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.062 · Cited by 559 · cited 2×
“…steatosis, a condition in which lipids are excessively accumulated in vesicles in the myocardium, is a hallmark of diabetic cardiomyopathy (Sharma et al. 2004; Rijzewijk et al. 2008; Schilling & Mann, 2012) that precedes the onset of diabetes and contractile dysfunction (McGavock et al. 2007).”
BackgroundForouhi, N. G., Koulman, A., Sharp, S. J., Imamura, F., Kröger, J., Schulze, M. B., Crowe, F. L., Huerta, J. M., Guevara, M., Beulens, J. W., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70146-9 · Cited by 557
Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., Taskinen, M.-R., Ehnholm, C., Keech, A., & on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1543 · Cited by 551
Bozkurt, B., Aguilar, D., Deswal, A., Dunbar, S. B., Francis, G. S., Horwich, T., Jessup, M., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 522
Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
Eguchi, K., Manabe, I., Oishi-Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.023 · Cited by 519
Wu, L., & Parhofer, K. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.08.010 · Cited by 516
Heart Failure with Preserved Ejection Fraction
Redfield, M. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1511175 · Cited by 510
Foundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamisligil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 505
Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy
Chiu, H.-C., Kovacs, A., Blanton, R. M., Han, X., Courtois, M., Weinheimer, C. J., Yamada, K. A., Brunet, S., Xu, H., Nerbonne, J. M., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000154079.20681.b9 · Cited by 467
Deactivation of peroxisome proliferator–activated receptor-α during cardiac hypertrophic growth
Barger, P. M., Brandt, J. M., Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9056 · Cited by 464
Fischer, J., Lefèvre, C., Morava, E., Mussini, J.-M., Laforêt, P., Negre-Salvayre, A., Lathrop, M., & Salvayre, R. (2007) · Nature Genetics · doi:10.1038/ng1951 · Cited by 461
Lloyd-Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Daly, D. D., DePalma, S. M., Minissian, M. B., Orringer, C. E., & Smith, S. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.519 · Cited by 459
Seimon, T. A., Nadolski, M. J., Liao, X., Magallon, J., Nguyen, M., Feric, N. T., Koschinsky, M. L., Harkewicz, R., Witztum, J. L., Tsimikas, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.010 · Cited by 457
An Integrated View of Immunometabolism
Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018) · Cell · doi:10.1016/j.cell.2017.12.025 · Cited by 436
Ceramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Yagyu, H., Chen, G., Yokoyama, M., Hirata, K., Augustus, A., Kako, Y., Seo, T., Hu, Y., Lutz, E. P., Merkel, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16751 · Cited by 394
Hypertriglyceridaemia and risk of coronary artery disease
Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 387
Patnode, C. D., Evans, C. V., Senger, C. A., Redmond, N., & Lin, J. S. (2017) · JAMA · doi:10.1001/jama.2017.3303 · Cited by 380
Lloyd-Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Daly, D. D., DePalma, S. M., Minissian, M. B., Orringer, C. E., & Smith, S. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.745 · Cited by 377
Arany, Z., Novikov, M., Chin, S., Ma, Y., Rosenzweig, A., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603615103 · Cited by 374
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Marwick, T. H., Ritchie, R., Shaw, J. E., & Kaye, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.019 · Cited by 365
A Redox-Dependent Pathway for Regulating Class II HDACs and Cardiac Hypertrophy
Ago, T., Liu, T., Zhai, P., Chen, W., Li, H., Molkentin, J. D., Vatner, S. F., & Sadoshima, J. (2008) · Cell · doi:10.1016/j.cell.2008.04.041 · Cited by 364
Self-citationAcylcarnitines—old actors auditioning for new roles in metabolic physiology
McCoin, C. S., Knotts, T. A., & Adams, S. H. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.129 · Cited by 344
Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
Frieler, R. A., & Mortensen, R. M. (2015) · Circulation · doi:10.1161/circulationaha.114.008788 · Cited by 334
Inflammation and metabolic cardiomyopathy
Nishida, K., & Otsu, K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx012 · Cited by 329
Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.09.011 · Cited by 319
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 317
Rijzewijk, L. J., van der Meer, R. W., Lamb, H. J., de Jong, H. W. A. M., Lubberink, M., Romijn, J. A., Bax, J. J., de Roos, A., Twisk, J. W., Heine, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.074 · Cited by 311
Chokshi, A., Drosatos, K., Cheema, F. H., Ji, R., Khawaja, T., Yu, S., Kato, T., Khan, R., Takayama, H., Knöll, R., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060889 · Cited by 296
Van Tassell, B. W., Arena, R., Biondi-Zoccai, G., McNair Canada, J., Oddi, C., Abouzaki, N. A., Jahangiri, A., Falcao, R. A., Kontos, M. C., Shah, K. B., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.047 · Cited by 281
Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.
Thaik, C. M., Calderone, A., Takahashi, N., & Colucci, W. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118095 · Cited by 272
Alshehry, Z. H., Mundra, P. A., Barlow, C. K., Mellett, N. A., Wong, G., McConville, M. J., Simes, J., Tonkin, A. M., Sullivan, D. R., Barnes, E. H., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023233 · Cited by 268
Increased Myocardial Fatty Acid Metabolism in Patients With Type 1 Diabetes Mellitus
Herrero, P., Peterson, L. R., McGill, J. B., Matthew, S., Lesniak, D., Dence, C., & Gropler, R. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.030 · Cited by 265
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
Roberts, L. D., Koulman, A., & Griffin, J. L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70143-8 · Cited by 263
Dietary fat: From foe to friend?
Ludwig, D. S., Willett, W. C., Volek, J. S., & Neuhouser, M. L. (2018) · Science · doi:10.1126/science.aau2096 · Cited by 257
Epstein, F. H., Kelly, D. P., & Strauss, A. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301308 · Cited by 257
Liu, Q., Docherty, J. C., Rendell, J. C. T., Clanachan, A. S., & Lopaschuk, G. D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01803-4 · Cited by 255
Shao, D., Oka, S.-I., Liu, T., Zhai, P., Ago, T., Sciarretta, S., Li, H., & Sadoshima, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.013 · Cited by 252
Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF
Tsujimoto, T., & Kajio, H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1111 · Cited by 228
Duncan, J. G., Fong, J. L., Medeiros, D. M., Finck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.106.662296 · Cited by 215
PGC-1α and ERRα target gene downregulation is a signature of the failing human heart
Sihag, S., Cresci, S., Li, A. Y., Sucharov, C. C., & Lehman, J. J. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.025 · Cited by 214
Ahmad, T., Kelly, J. P., McGarrah, R. W., Hellkamp, A. S., Fiuzat, M., Testani, J. M., Wang, T. S., Verma, A., Samsky, M. D., Donahue, M. P., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.079 · Cited by 214
Elam, M. B., Ginsberg, H. N., Lovato, L. C., Corson, M., Largay, J., Leiter, L. A., Lopez, C., O’Connor, P. J., Sweeney, M. E., Weiss, D., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4828 · Cited by 185
Campbell, R. T., Jhund, P. S., Castagno, D., Hawkins, N. M., Petrie, M. C., & McMurray, J. J. V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.064 · Cited by 179
Interaction Between NFκB and NFAT Coordinates Cardiac Hypertrophy and Pathological Remodeling
Liu, Q., Chen, Y., Auger-Messier, M., & Molkentin, J. D. (2012) · Circulation Research · doi:10.1161/circresaha.111.260729 · Cited by 169
Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1589 · Cited by 164
Ko, H. J., Zhang, Z., Jung, D. Y., Jun, J. Y., Ma, Z., Jones, K. E., Chan, S. Y., & Kim, J. K. (2009) · Diabetes · doi:10.2337/db08-1361 · Cited by 159
Increased de novo ceramide synthesis and accumulation in failing myocardium
Ji, R., Akashi, H., Drosatos, K., Liao, X., Jiang, H., Kennel, P. J., Brunjes, D. L., Castillero, E., Zhang, X., Deng, L. Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96203 · Cited by 159
Increased de novo ceramide synthesis and accumulation in failing myocardium
Ji, R., Akashi, H., Drosatos, K., Liao, X., Jiang, H., Kennel, P. J., Brunjes, D. L., Castillero, E., Zhang, X., Deng, L. Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.82922 · Cited by 159
Woodiwiss, A. J., Libhaber, C. D., Majane, O. H. I., Libhaber, E., Maseko, M. J., & Norton, G. R. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.252 · Cited by 155
Mathur, A., Sims, H. F., Gopalakrishnan, D., Gibson, B., Rinaldo, P., Vockley, J. E., Hug, G., & Strauss, A. W. (1999) · Circulation · doi:10.1161/01.cir.99.10.1337 · Cited by 152
Fruchart, J.-C. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0602-y · Cited by 141
Sverdlov, A. L., Elezaby, A., Qin, F., Behring, J. B., Luptak, I., Calamaras, T. D., Siwik, D. A., Miller, E. J., Liesa, M., Shirihai, O. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002555 · Cited by 137
Dietary Fat and Heart Failure: Moving From Lipotoxicity to Lipoprotection
Stanley, W. C., Dabkowski, E. R., Júnior, R. F. R., & O’Connell, K. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.253104 · Cited by 133
Paneni, F., & Lüscher, T. F. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.04.008 · Cited by 125
Schilling, J. D., & Mann, D. L. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.007 · Cited by 124
Carbotoxicity—Noxious Effects of Carbohydrates
Kroemer, G., López-Otín, C., Madeo, F., & de Cabo, R. (2018) · Cell · doi:10.1016/j.cell.2018.07.044 · Cited by 124
Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy
Nakamura, M., Liu, T., Husain, S., Zhai, P., Warren, J. S., Hsu, C., Matsuda, T., Phiel, C. J., Cox, J. E., Tian, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.005 · Cited by 116
Self-citationTong, X., Hou, X., Jourd’heuil, D., Weisbrod, R. M., & Cohen, R. A. (2010) · Circulation Research · doi:10.1161/circresaha.110.221242 · Cited by 112
Quispe, R., Martin, S. S., & Jones, S. R. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000241 · Cited by 98
Dong, B., Qi, D., Yang, L., Huang, Y., Xiao, X., Tai, N., Li, W., & Wong, F. S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00948.2011 · Cited by 96
Pyridine Nucleotide Regulation of Cardiac Intermediary Metabolism
Ussher, J. R., Jaswal, J. S., & Lopaschuk, G. D. (2012) · Circulation Research · doi:10.1161/circresaha.111.246371 · Cited by 94
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart
SHARMA, S., GUTHRIE, P., Chan, S., HAQ, S., & Taegtmeyer, H. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.004 · Cited by 93
Overview of Pyridine Nucleotides Review Series
Nakamura, M., Bhatnagar, A., & Sadoshima, J. (2012) · Circulation Research · doi:10.1161/circresaha.111.247924 · Cited by 93
Self-citationDyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats
Shao, C.-H., Rozanski, G. J., Patel, K. P., & Bidasee, K. R. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.018 · Cited by 90
the Shinken Database Study Group, Nakamura, M., Yamashita, T., Yajima, J., Oikawa, Y., Sagara, K., Koike, A., Kirigaya, H., Nagashima, K., Sawada, H., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.126 · Cited by 88
Self-citationPaneni, F., & Lüscher, T. F. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.015 · Cited by 83
Tocchetti, C. G., Caceres, V., Stanley, B. A., Xie, C., Shi, S., Watson, W. H., O'Rourke, B. P., Spadari-Bratfisch, R. C., Cortassa, S. C., Akar, F. G., et al. (2012) · Diabetes · doi:10.2337/db12-0072 · Cited by 80
Transcriptional Control of Cardiac Fuel Metabolism and Mitochondrial FunctionPreprint
Leone, T. C., & Kelly, D. P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011965 · Cited by 78
Cardiac nuclear receptors: architects of mitochondrial structure and function
Vega, R. B., & Kelly, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88888 · Cited by 74
Thomas, C., Yong, Q. C., Rosa, R. M., Seqqat, R., Gopal, S., Casarini, D. E., Jones, W. K., Gupta, S., Baker, K. M., & Kumar, R. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00340.2014 · Cited by 70
Aasum, E., Khalid, A. M., Gudbrandsen, O. A., How, O.-J., Berge, R. K., & Larsen, T. S. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.020 · Cited by 63
Meta-Analysis of the Effect of Statins on Mortality in Patients With Preserved Ejection Fraction
Liu, G., Zheng, X., Xu, Y.-L., Ru, J., Hui, R., & Huang, X. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.023 · Cited by 63
Heart Failure With Preserved Ejection Fraction
Lam, C. S. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.034 · Cited by 54
Effect of glucose-lowering therapies on heart failure
Nassif, M. E., & Kosiborod, M. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.211 · Cited by 54
Mitra, R., Nogee, D., Zechner, J. F., Yea, K., Gierasch, C. M., Kovács, A. D., Medeiros, D. M., Kelly, D. P., & Duncan, J. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.10.010 · Cited by 51
Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure
Sarma, S., Ardehali, H., & Gheorghiade, M. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9208-0 · Cited by 48
Elmariah, S., Farrell, L. A., Furman, D., Lindman, B. R., Shi, X. D., Morningstar, J. E., Rhee, E. P., & Gerszten, R. E. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4873 · Cited by 37
Cheng, Y., Li, W., McElfresh, T. A., Chen, X., Berthiaume, J. M., Castel, L., Yu, X., Wagoner, D. R. V., & Chandler, M. P. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00440.2011 · Cited by 19
Venäläinen, T. M., Viitasalo, A., Schwab, U., Eloranta, A., Haapala, E. A., Jalkanen, H., de Mello, V. D., Laaksonen, D. E., Lindi, V., Ågren, J. J., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.136580 · Cited by 19
Downing, N. S., Cheng, T. M., Krumholz, H. M., Shah, N. D., & Ross, J. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1371 · Cited by 15
Cited by
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., Oliveira, G. M. M. D., Simão, A. F., Dutra, O. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R. M. D. S., Giuliano, I. D. C. B., Alencar Filho, A. C. D., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 434
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Petucci, C., Kim, M.-S., Bedi, K. C., Wang, H., Mishra, S., Koleini, N., Yoo, E. J., Margulies, K. B., Arany, Z., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061846 · Cited by 294
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Metadata
- Authors
- Nakamura, M., & Sadoshima, J.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2019-04-03
- Volume
- 598
- Issue
- 14
- Pages
- 2977-2993
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2920835192
- Cited by
- 286
- References
- 159
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.